123 related articles for article (PubMed ID: 10468339)
1. Prognostic factors relating to survival in uterine endometrioid carcinoma.
Hirai M; Hirono M; Oosaki T; Hayashi Y; Yoshihara T; Matsuzaki O
Int J Gynaecol Obstet; 1999 Aug; 66(2):155-62. PubMed ID: 10468339
[TBL] [Abstract][Full Text] [Related]
2. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
Taneichi A; Fujiwara H; Takahashi Y; Takei Y; Machida S; Saga Y; Takahashi S; Suzuki M
Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
[TBL] [Abstract][Full Text] [Related]
3. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
5. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma.
Mylonas I; Schindlbeck C
Arch Gynecol Obstet; 2012 Jan; 285(1):207-14. PubMed ID: 21538008
[TBL] [Abstract][Full Text] [Related]
6. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.
Greggi S; Mangili G; Scaffa C; Scala F; Losito S; Iodice F; Pisano C; Montoli S; Viganò R; Pirozzi G; Giannarelli D
Int J Gynecol Cancer; 2011 May; 21(4):661-7. PubMed ID: 21412164
[TBL] [Abstract][Full Text] [Related]
7. Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus.
Ambros RA; Ballouk F; Malfetano JH; Ross JS
Am J Surg Pathol; 1994 Jun; 18(6):569-75. PubMed ID: 8179072
[TBL] [Abstract][Full Text] [Related]
8. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
9. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type].
Stanojević Z; Dordević B
Vojnosanit Pregl; 2006 Dec; 63(12):1006-10. PubMed ID: 17252704
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
[TBL] [Abstract][Full Text] [Related]
12. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma.
Garuti G; De Giorgi O; Sambruni I; Cellani F; Luerti M
Gynecol Oncol; 2001 Jun; 81(3):408-13. PubMed ID: 11371130
[TBL] [Abstract][Full Text] [Related]
14. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer.
Chan JK; Kapp DS; Cheung MK; Shin JY; Stieglitz D; Husain A; Teng NN; Berek JS; Osann K; Guo H
Am J Obstet Gynecol; 2008 Feb; 198(2):216.e1-5. PubMed ID: 18226629
[TBL] [Abstract][Full Text] [Related]
16. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence.
Fujimoto T; Nanjyo H; Fukuda J; Nakamura A; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2009 Feb; 112(2):342-7. PubMed ID: 19062082
[TBL] [Abstract][Full Text] [Related]
17. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
[TBL] [Abstract][Full Text] [Related]
18. Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement.
Zaki MA; Robbins JR; Fatteh S; Mahan MG; Hanna RK; Elshaikh MA
Anticancer Res; 2012 Sep; 32(9):4061-5. PubMed ID: 22993361
[TBL] [Abstract][Full Text] [Related]
19. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
[TBL] [Abstract][Full Text] [Related]
20. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
